Repurposing aspartic protease inhibitors as novel antimalarial agents

被引：0
|
作者：
Meyers, Marvin [1 ]
机构：
[1] St Louis Univ, Ctr World Hlth & Med, Wentzville, MO USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
260
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Antimalarial synergy of cysteine and aspartic protease inhibitors
    Semenov, A
    Olson, JE
    Rosenthal, PJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2254 - 2258
  • [2] Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents
    Boss, C
    Richard-Bildstein, S
    Weller, T
    Fischli, W
    Meyer, S
    Binkert, C
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (11) : 883 - 907
  • [3] Inhibitors of aspartic proteases - potential antimalarial agents
    Boss, C
    Corminboeuf, O
    Grisostomi, C
    Weller, T
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (03) : 295 - 317
  • [4] Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents
    Micale, Nicola
    Kozikowski, Alan P.
    Ettari, Roberta
    Grasso, Silvana
    Zappala, Maria
    Jeong, Jong-Jin
    Kumar, Ajay
    Hanspal, Manjit
    Chishti, Athar H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (11) : 3064 - 3067
  • [5] A novel class of Plasmodial ClpP protease inhibitors as potential antimalarial agents
    Mundra, Sourabh
    Thakur, Vandana
    Bello, Angelica M.
    Rathore, Sumit
    Asad, Mohd
    Wei, Lianhu
    Yang, Jane
    Chakka, Sai Kumar
    Mahesh, Radhakrishnan
    Malhotra, Pawan
    Mohmmed, Asif
    Kotra, Lakshmi P.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (20) : 5662 - 5677
  • [6] Antimalarial activities of novel synthetic cysteine protease inhibitors
    Lee, BJ
    Singh, A
    Chiang, P
    Kemp, SJ
    Goldman, EA
    Weinhouse, MI
    Vlasuk, GP
    Rosenthal, PJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) : 3810 - 3814
  • [7] Characterisation of hydrazides and hydrazine derivatives as novel aspartic protease inhibitors
    Ahmed, Waseem
    Rani, Mubeen
    Khan, Ishtiaq A.
    Iqbal, Asif
    Khan, Khalid M.
    Haleem, M. A.
    Azim, M. Kamran
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2010, 25 (05) : 673 - 678
  • [8] Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents
    Ruoxi Li
    Dazheng Ling
    Tongke Tang
    Zhenghui Huang
    Manjiong Wang
    Fei Mao
    Jin Zhu
    Lubin Jiang
    Jian Li
    Xiaokang Li
    ChineseChemicalLetters, 2021, 32 (05) : 1660 - 1664
  • [9] Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents
    Li, Ruoxi
    Ling, Dazheng
    Tang, Tongke
    Huang, Zhenghui
    Wang, Manjiong
    Mao, Fei
    Zhu, Jin
    Jiang, Lubin
    Li, Jian
    Li, Xiaokang
    CHINESE CHEMICAL LETTERS, 2021, 32 (05) : 1660 - 1664
  • [10] Biologic protease inhibitors as novel therapeutic agents
    Scott, Christopher J.
    Taggart, Clifford C.
    BIOCHIMIE, 2010, 92 (11) : 1681 - 1688
12345